Fed Sinks Markets
Health Care: Drugs
Celsion Corporation (CLSN: NASDAQ)
$1.22 -0.09 | -6.87%
06/19/13 - 04:00 PM ET
TheStreet Ratings Grade for CLSN
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 2 | 2 |
| Mean Rec. | 4.00 | 3.67 | 4.33 | 4.33 |
Portfolios with CLSN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- UserWatch
- UserBIO
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- ContributorTop 5 Small-Cap Stocks to C...
Latest CLSN Headlines from TheStreet
- Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion 06.14.13 | 07:06 am
- Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You) 06.11.13 | 07:06 am
- The 5 Dumbest Things on Wall Street This Week 04.26.13 | 07:04 am
- 5 Dumbest Things on Wall Street
04.26.13 | 07:04 am - Celsion's Shameless Spin Job (Update) 04.23.13 | 05:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- 4 Stocks Under $10 Spiking Higher 03.08.13 | 07:03 am
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Ziopharm's Sarcoma Study And The Feuerstein-Ratain Rule 02.05.13 | 06:02 am
- Stocks Surge After January Jobs Report; Dow Eclipses 14,000 02.01.13 | 02:02 pm
Press Releases for CLSN
- The Rosen Law Firm Announces Investigation Of Securities Claims Against Celsion Corp. – CLSN - Business Wire 06.17.13 | 01:06 am
- Celsion Corporation Issues Statement Regarding Misleading Blog Entry - PR Newswire 06.12.13 | 03:06 pm
- Celsion Corporation Announces $9.83 Million Registered Direct Offering - PR Newswire 05.31.13 | 10:05 am
- Celsion Announces ThermoDox® HEAT Study Findings To Be Presented At The 2013 European Conference On Interventional Oncology (ECIO) In Budapest, Hungary On June 19 And 20, 2013 - PR Newswire 05.30.13 | 08:05 am
- Celsion Announces Issuance Of Additional Patents Covering ThermoDox® Technologies - PR Newswire 05.22.13 | 08:05 am
- Celsion's ThermoDox® HEAT Study Findings Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) - PR Newswire 05.17.13 | 08:05 am
- Celsion Corporation To Hold First Quarter 2013 Financial Results Conference Call On Thursday, May 9, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Announces ThermoDox® HEAT Study Findings To Be Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) In New York City On May 16, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Corporation Provides Business Update - PR Newswire 04.23.13 | 08:04 am
- Celsion Corporation To Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013 - PR Newswire 03.12.13 | 08:03 am
Partner Headlines for CLSN
- Afternoon Market Losers - Benzinga 06.14.13 | 02:06 pm
- Celsion: Raised From The Dead - Seeking Alpha 06.04.13 | 09:06 am
- Amarin & Celsion: Post-Earnings Roundup - Seeking Alpha 05.15.13 | 09:05 am
- Celsion Shares Rally as Co. Hires Cantor Fitzgerald to Evaluate Purchase Alternatives, Study Shows Thermodox Improves PFS with Optimized Heating - Benzinga 04.23.13 | 09:04 am
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- A 2013 Diversified Bullish Portfolio In 10 Positions - Seeking Alpha 02.28.13 | 09:02 am
- After Phase III Failure, Celsion Is Still Worthless - Seeking Alpha 02.12.13 | 09:02 am
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Celsion Stock Blown Apart On Thermodox Phase III Data - Seeking Alpha 02.02.13 | 09:02 am
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
